The Intracept Procedure

for the Relief of Chronic Low Back Pain


The Intracept Procedure was developed based on two decades of scientific research on the existence of the basivertebral nerve and its role in chronic low back pain. Intracept is a minimally invasive procedure that targets the basivertebral nerve for the relief of chronic low back pain.


Key Benefits of Intracept

  • Provides a treatment option for patients who have not responded to conservative therapy
  • Minimally invasive, outpatient procedure
  • Implant-free and preserves the structure of the spine
  • Provides durable relief of chronic low back pain1

Intracept Procedure Steps

  • 1 Access the pedicle

    Under fluoroscopic guidance, the Intracept Introducer Cannula is advanced through the pedicle

  • 2 Create the channel

    The Intracept Curved Cannula is utilized to create a channel to the trunk of the basivertebral nerve

  • 3 Place the RF Probe

    The Intracept Radiofrequency Probe is inserted into the curved path and placed at the basivertebral nerve

  • 4 Ablate the BVN

    The Relievant Radiofrequency Generator is utilized to ablate the basivertebral nerve


Patient Selection

  • Chronic Low Back Pain of at least 6 months
  • Not responded to at least 6 months of conservative care
  • Type 1 or Type 2 Modic changes on an MRI (Figure 2)

Indications, Contraindications and Risks

The Intracept Intraosseous Nerve Ablation System is intended to be used in conjunction with radiofrequency (RF) generators for the ablation of basivertebral nerves of the L3 through S1 vertebrae for the relief of chronic low back pain of at least six months duration that has not responded to at least six months of conservative care, and is also accompanied by either Type 1 or Type 2 Modic changes on an MRI.

Use of the Intracept Intraosseous Nerve Ablation System is contraindicated in:

  • Patients with severe cardiac or pulmonary compromise
  • Patients where the targeted ablation zone is < 10 mm away from a sensitive structure not intended to be ablated, including the vertebral foramen (spinal canal)
  • Patients with active systemic infection or local infection in the area to be treated
  • Patients who are pregnant
  • Skeletally immature patients (generally < 18 years of age)
  • Patients with implantable pulse generators (e.g., pacemakers, defibrillators) or other electronic implants
  • Situations where unintended tissue damage may result, based on the clinical assessment by the physician
  • Application with electrosurgical instruments NOT tested and specified for use with the Relievant RFG

As with any surgical procedure, there are risks and considerations associated with the Intracept Procedure. To review the contraindications, warnings and precautions click here.